{"id":18153,"date":"2024-08-30T10:00:19","date_gmt":"2024-08-30T08:00:19","guid":{"rendered":"https:\/\/world-heart-federation.org\/?post_type=news&p=18153"},"modified":"2024-08-30T13:18:46","modified_gmt":"2024-08-30T11:18:46","slug":"a-quarter-of-patients-in-whf-study-still-experiencing-persistent-long-covid-symptom-after-one-year","status":"publish","type":"news","link":"https:\/\/world-heart-federation.org\/news\/a-quarter-of-patients-in-whf-study-still-experiencing-persistent-long-covid-symptom-after-one-year\/","title":{"rendered":"A quarter of patients in WHF Study still experiencing persistent long COVID symptom after one year"},"content":{"rendered":"
Following the success of the Global Study on Cardiovascular Disease (CVD) and COVID-19, and to better understand long COVID<\/span>, especially in low-resource settings, World Heart Federation (WHF) commenced the WHF Long COVID Sub-study in early 2022. This sub-study aimed to determine the short-term (3 months), medium-term (6 months), and long-term (12 months) sequelae of COVID-19, including re-hospitalization and mortality, symptoms, impact on physical function, and psycho-social consequences. Twenty-six hospitals from 16 countries (Bangladesh, Brazil, Colombia, India, Indonesia, Iran, Japan, Kenya, Malaysia, Mexico, Nigeria, Pakistan, Portugal, Russia, South Africa, Zambia) recruited 2,535 hospitalized COVID-19 patients from January 2022 to August 2023. Subsequently, these patients were contacted via telephone for follow-up assessments at four different time points: 1-month, 3-months, 6-months, and 9-12-month after hospital discharge. Follow ups for all eligible patients were completed in January 2024, with a follow-up rate of 90%.<\/p>\n The results presented at the ESC Congress 2024 reveal a significant burden of persistent long COVID symptoms among hospitalized COVID-19 patients. Most patients tested positive for the Omicron variant, and the discharged population experienced substantial mortality and morbidity rates. About a quarter of these patients reported at least one persistent long COVID symptom after one year.<\/p>\n These findings can help identify high-risk COVID-19 patients and inform management strategies for long COVID, especially in low and middle-income countries. The final results are to be published later this year and can help guide future health care planning for the post pandemic globally.<\/p>\n","protected":false},"excerpt":{"rendered":" Following the success of the Global Study on Cardiovascular Disease (CVD) and COVID-19, and to better understand long COVID, especially in low-resource settings, World Heart Federation (WHF) commenced the WHF Long COVID Sub-study in early 2022. This sub-study aimed to determine the short-term (3 months), medium-term (6 months), and long-term (12 months) sequelae of COVID-19, […]<\/p>\n","protected":false},"featured_media":18175,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"event":[],"project-campaign":[],"topic":[],"class_list":["post-18153","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n\n
<\/p>\n